United States Healthcare Providers & Services

Elevance Health Inc (ELV)

Elevance Health Inc. experienced significant insider trading activity over the past ninety days, totaling over five million dollars in net sales. Executives, including the CFO and Chief Digital Officer, offloaded shares following the latest earnings report. These sixteen transactions reflect a consistent divestment pattern by leadership while the stock price maintains a strong position near yearly highs.
Ticker: ELV Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Elevance Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
LAVU RATNAKAR EVP & Chief Digital Info Ofr Officer
Transaction date
Sale
Price
255.94
Quantity 53,625 -26.3%
Value US$2,679,613
RATNAKAR LAVU Officer Officer
Transaction date
Proposed sale
Price
269.83
Quantity 82,667
Value US$2,984,060
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
21.74
Quantity 14,841 +35.5%
Value US$4,825,492
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
446.05
Quantity 1,000 -3.9%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
444.85
Quantity 1,000 -0.8%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
443.81
Quantity 1,000 -2.0%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
442.61
Quantity 1,000 -2.2%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
441.34
Quantity 1,000 -9.6%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
440.44
Quantity 1,000 -6.6%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
439.25
Quantity 1,000 -4.2%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
438.22
Quantity 1,000 -0.9%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
437.07
Quantity 1,000 -2.0%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
436.20
Quantity 1,000 -5.6%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
435.25
Quantity 1,000 -1.1%
Value US$100,000
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
434.00
Quantity 1,000 -1.3%
Value US$100,000
2.7
MARK B KAYE Officer Officer
Transaction date
Proposed sale
Price
440.13
Quantity 1,000
Value US$100,000
3.6
PERU RAMIRO G Non-Executive Director
Transaction date
Purchase
Price
366.05
Quantity 1,000 +10.1%
Value US$366,050
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Purchase
Price
368.25
Quantity 2,045 +1.2%
Value US$753,071
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Purchase
Price
366.41
Quantity 680 +0.4%
Value US$249,159
2.8
CLARK R KERRY Director Non-Executive Director
Transaction date
Proposed sale
Price
419.91
Quantity 1,500
Value US$629,865
2.7
Penczek Ronald W CAO & Controller Officer
Transaction date
Sale
Price
403.16
Quantity 369 -9.0%
Value US$148,766
2.7
RONALD WILLIAM PENCZEK Officer Officer
Transaction date
Proposed sale
Price
403.16
Quantity 369
Value US$148,767
3.6
Dixon Robert L JR Non-Executive Director
Transaction date
Sale
Price
401.77
Quantity 151 -1.4%
Value US$60,667
3.6
Dixon Robert L JR Non-Executive Director
Transaction date
Sale
Price
401.77
Quantity 151 -1.4%
Value US$60,667
3.6
Dixon Robert L JR Director Non-Executive Director
Transaction date
Proposed sale
Price
401.76
Quantity 151
Value US$60,666
2.7
Penczek Ronald W CAO & Controller Officer
Transaction date
Sale
Price
403.13
Quantity 1,531 -27.1%
Value US$617,192
2.7
RONALD WILLIAM PENCZEK Officer Officer
Transaction date
Proposed sale
Price
403.13
Quantity 1,531
Value US$617,192
2.6
SCHULMAN AMY W Non-Executive Director
Transaction date
Sale
Price
287.50
Quantity 26 -10.7%
Value US$7,475
3.2
Kendrick Charles Morgan JR EVP & President, Commercial Officer
Transaction date
Sale
Price
284.92
Quantity 3,196 -21.3%
Value US$910,604
3.2
CHARLES MORGAN KENDRICK Officer Officer
Transaction date
Proposed sale
Price
284.92
Quantity 3,196
Value US$910,593
2.9
COLLIS STEVEN H Non-Executive Director
Transaction date
Purchase
Price
289.84
Quantity 3,000 +469.5%
Value US$869,520
2.1
DeVore Susan D. Non-Executive Director
Transaction date
Purchase
Price
312.15
Quantity 1,200 +52.1%
Value US$374,580
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Purchase
Price
287.96
Quantity 1,050 +0.7%
Value US$302,358
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Purchase
Price
287.12
Quantity 5,116 +3.5%
Value US$1,468,906
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Purchase
Price
286.07
Quantity 2,334 +1.6%
Value US$667,687
2.7
Kaye Mark EVP & CFO Officer
Transaction date
Sale
Price
424.82
Quantity 4,588 -19.5%
Value US$1,949,074
2.7
Kaye Mark Officer Officer
Transaction date
Proposed sale
Price
424.82
Quantity 4,588
Value US$1,949,051
2.7
Penczek Ronald W CAO & Controller Officer
Transaction date
Sale
Price
415.13
Quantity 443 -19.3%
Value US$183,903
2.7
Penczek Ronald W Officer Officer
Transaction date
Proposed sale
Price
415.13
Quantity 443
Value US$183,904
3.2
Kendrick Charles Morgan JR Officer Officer
Transaction date
Proposed sale
Price
396.30
Quantity 3,504
Value US$1,388,651
3.2
Kendrick Charles Morgan JR EVP & President, Commercial Officer
Transaction date
Sale
Price
396.30
Quantity 3,504 -25.7%
Value US$1,388,635
3.2
Kendrick Charles Morgan JR Director Non-Executive Director
Transaction date
Proposed sale
Price
432.28
Quantity 7,417
Value US$3,206,221
3.2
Kendrick Charles Morgan JR EVP & President, Commercial Officer
Transaction date
Sale
Price
432.14
Quantity 7,417 -46.8%
Value US$3,205,182
3.6
PERU RAMIRO G Non-Executive Director
Transaction date
Planned sale
Price
531.52
Quantity 753 -7.9%
Value US$400,235
3.6
RAMIRO G PERU Director Non-Executive Director
Transaction date
Proposed sale
Price
531.52
Quantity 753
Value US$400,235
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Planned sale
Price
504.27
Quantity 2,250 -1.7%
Value US$1,134,608
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Planned sale
Price
503.67
Quantity 1,000 -0.8%
Value US$503,670
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Planned sale
Price
502.23
Quantity 2,250 -1.7%
Value US$1,130,018
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Planned sale
Price
501.40
Quantity 6,621 -4.8%
Value US$3,319,769
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Planned sale
Price
500.36
Quantity 20,779 -13.0%
Value US$10,396,980
3.8
BOUDREAUX GAIL President and CEO Executive Director
Transaction date
Planned sale
Price
498.50
Quantity 1,100 -0.7%
Value US$548,350
3.8
GAIL A KOZIARA BOUDREAUX Officer; Director Executive Director
Transaction date
Proposed sale
Price
500.98
Quantity 34,000
Value US$17,033,398
3.6
Dixon Robert L JR Non-Executive Director
Transaction date
Sale
Price
506.76
Quantity 305 -3.0%
Value US$154,562
3.6
ROBERT DIXON Director Non-Executive Director
Transaction date
Proposed sale
Price
506.76
Quantity 305
Value US$154,562
2.1
Norwood Felicia F EVP & President,Gov Health Ben Officer
Transaction date
Sale
Price
532.68
Quantity 3,434 -11.2%
Value US$1,829,223
2.1
Norwood Felicia F EVP & President,Gov Health Ben Officer
Transaction date
Sale
Price
532.14
Quantity 2,765 -8.3%
Value US$1,471,367
2.1
Norwood Felicia F EVP & President,Gov Health Ben Officer
Transaction date
Sale
Price
534.74
Quantity 100 -0.3%
Value US$53,474
2.1
Norwood Felicia F EVP & President,Gov Health Ben Officer
Transaction date
Sale
Price
533.73
Quantity 14,011 -30.7%
Value US$7,478,091
2.1
Norwood Felicia F Officer Officer
Transaction date
Proposed sale
Price
533.60
Quantity 20,310
Value US$10,837,416
3.2
Kendrick Charles Morgan JR EVP & President, Commercial Officer
Transaction date
Sale
Price
500.46
Quantity 2,432 -13.3%
Value US$1,217,119
3.2
Kendrick Charles Morgan JR Officer Officer
Transaction date
Proposed sale
Price
500.46
Quantity 2,432
Value US$1,217,119
2.7
Penczek Ronald W CAO & Controller Officer
Transaction date
Sale
Price
504.58
Quantity 916 -34.2%
Value US$462,195
2.7
Penczek Ronald W Officer Officer
Transaction date
Proposed sale
Price
504.58
Quantity 916
Value US$462,197
1.4
Haytaian Peter D EVP & Pres Carelon & CarelonRx Officer
Transaction date
Planned sale
Price
500.18
Quantity 15,000 -44.3%
Value US$7,502,700
1.4
Haytaian Peter D EVP & Pres Carelon & CarelonRx Officer
Transaction date
Planned sale
Price
500.18
Quantity 1,889 -5.3%
Value US$944,840
1.4
Haytaian Peter D EVP & Pres Carelon & CarelonRx Officer
Transaction date
Planned sale
Price
500.18
Quantity 4,206 -10.5%
Value US$2,103,757
1.4
PETER D HAYTAIAN Officer Officer
Transaction date
Proposed sale
Price
500.18
Quantity 21,095
Value US$10,551,297
3.6
PERU RAMIRO G Non-Executive Director
Transaction date
Planned sale
Price
500.00
Quantity 753 -7.6%
Value US$376,500
3.6
RAMIRO G PERU Director Non-Executive Director
Transaction date
Proposed sale
Price
500.00
Quantity 753
Value US$376,500
1.6
Todt Blair Williams EVP, CLO & CAO Officer
Transaction date
Sale
Price
484.02
Quantity 5,492 -30.5%
Value US$2,658,238
1.6
Todt Blair Williams Officer Officer
Transaction date
Proposed sale
Price
484.02
Quantity 5,492
Value US$2,658,238
2.7
Penczek Ronald W CAO & Controller Officer
Transaction date
Sale
Price
475.17
Quantity 1,055 -37.1%
Value US$501,304
2.7
Penczek Ronald W Officer Officer
Transaction date
Proposed sale
Price
475.17
Quantity 1,055
Value US$501,300
2.7
Penczek Ronald W CAO & Controller Officer
Transaction date
Sale
Price
454.35
Quantity 64 -2.2%
Value US$29,078
3.6
ROBERT DIXON JR Director Non-Executive Director
Transaction date
Proposed sale
Price
476.71
Quantity 310
Value US$147,781
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-06 2026-11-05 S Sale
LAVU RATNAKAR

EVP & Chief Digital Info Ofr

Officer
53,625 -26.3%
255.94
US$2,679,613 		53,625 -26.3% 255.94 US$2,679,613
2026-11-05 2026-11-05 PrS Proposed sale
RATNAKAR LAVU

Officer

Officer
82,667
269.83
US$2,984,060 		82,667 269.83 US$2,984,060
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
14,841 +35.5%
21.74
US$4,825,492 		14,841 +35.5% 21.74 US$4,825,492
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -3.9%
446.05
US$100,000 		1,000 -3.9% 446.05 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -0.8%
444.85
US$100,000 		1,000 -0.8% 444.85 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -2.0%
443.81
US$100,000 		1,000 -2.0% 443.81 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -2.2%
442.61
US$100,000 		1,000 -2.2% 442.61 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -9.6%
441.34
US$100,000 		1,000 -9.6% 441.34 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -6.6%
440.44
US$100,000 		1,000 -6.6% 440.44 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -4.2%
439.25
US$100,000 		1,000 -4.2% 439.25 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -0.9%
438.22
US$100,000 		1,000 -0.9% 438.22 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -2.0%
437.07
US$100,000 		1,000 -2.0% 437.07 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -5.6%
436.20
US$100,000 		1,000 -5.6% 436.20 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -1.1%
435.25
US$100,000 		1,000 -1.1% 435.25 US$100,000
2026-10-23 2026-10-22 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
1,000 -1.3%
434.00
US$100,000 		1,000 -1.3% 434.00 US$100,000
2026-10-22 2026-10-22 PrS Proposed sale
2.7
MARK B KAYE

Officer

Officer
1,000
440.13
US$100,000 		1,000 440.13 US$100,000
2026-07-17 2026-07-17 B Purchase
3.6
PERU RAMIRO G
Non-Executive Director
1,000 +10.1%
366.05
US$366,050 		1,000 +10.1% 366.05 US$366,050
2026-07-17 2026-07-17 B Purchase
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
2,045 +1.2%
368.25
US$753,071 		2,045 +1.2% 368.25 US$753,071
2026-07-17 2026-07-17 B Purchase
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
680 +0.4%
366.41
US$249,159 		680 +0.4% 366.41 US$249,159
2026-07-07 2026-07-07 PrS Proposed sale
2.8
CLARK R KERRY

Director

Non-Executive Director
1,500
419.91
US$629,865 		1,500 419.91 US$629,865
2026-06-15 2026-06-12 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
369 -9.0%
403.16
US$148,766 		369 -9.0% 403.16 US$148,766
2026-06-12 2026-06-12 PrS Proposed sale
2.7
RONALD WILLIAM PENCZEK

Officer

Officer
369
403.16
US$148,767 		369 403.16 US$148,767
2026-06-12 2026-06-11 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
151 -1.4%
401.77
US$60,667 		151 -1.4% 401.77 US$60,667
2026-06-12 2026-06-11 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
151 -1.4%
401.77
US$60,667 		151 -1.4% 401.77 US$60,667
2026-06-11 2026-06-11 PrS Proposed sale
3.6
Dixon Robert L JR

Director

Non-Executive Director
151
401.76
US$60,666 		151 401.76 US$60,666
2026-05-20 2026-05-19 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
1,531 -27.1%
403.13
US$617,192 		1,531 -27.1% 403.13 US$617,192
2026-05-19 2026-05-19 PrS Proposed sale
2.7
RONALD WILLIAM PENCZEK

Officer

Officer
1,531
403.13
US$617,192 		1,531 403.13 US$617,192
2026-03-23 2026-03-12 S Sale
2.6
SCHULMAN AMY W
Non-Executive Director
26 -10.7%
287.50
US$7,475 		26 -10.7% 287.50 US$7,475
2026-03-09 2026-03-06 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
3,196 -21.3%
284.92
US$910,604 		3,196 -21.3% 284.92 US$910,604
2026-03-06 2026-03-06 PrS Proposed sale
3.2
CHARLES MORGAN KENDRICK

Officer

Officer
3,196
284.92
US$910,593 		3,196 284.92 US$910,593
2026-03-06 2026-03-05 B Purchase
2.9
COLLIS STEVEN H
Non-Executive Director
3,000 +469.5%
289.84
US$869,520 		3,000 +469.5% 289.84 US$869,520
2025-08-21 2025-08-19 B Purchase
2.1
DeVore Susan D.
Non-Executive Director
1,200 +52.1%
312.15
US$374,580 		1,200 +52.1% 312.15 US$374,580
2025-07-18 2025-07-18 B Purchase
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
1,050 +0.7%
287.96
US$302,358 		1,050 +0.7% 287.96 US$302,358
2025-07-18 2025-07-18 B Purchase
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
5,116 +3.5%
287.12
US$1,468,906 		5,116 +3.5% 287.12 US$1,468,906
2025-07-18 2025-07-18 B Purchase
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
2,334 +1.6%
286.07
US$667,687 		2,334 +1.6% 286.07 US$667,687
2025-04-25 2025-04-24 S Sale
2.7
Kaye Mark

EVP & CFO

Officer
4,588 -19.5%
424.82
US$1,949,074 		4,588 -19.5% 424.82 US$1,949,074
2025-04-24 2025-04-24 PrS Proposed sale
2.7
Kaye Mark

Officer

Officer
4,588
424.82
US$1,949,051 		4,588 424.82 US$1,949,051
2025-03-11 2025-03-10 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
443 -19.3%
415.13
US$183,903 		443 -19.3% 415.13 US$183,903
2025-03-10 2025-03-10 PrS Proposed sale
2.7
Penczek Ronald W

Officer

Officer
443
415.13
US$183,904 		443 415.13 US$183,904
2025-03-05 2025-03-05 PrS Proposed sale
3.2
Kendrick Charles Morgan JR

Officer

Officer
3,504
396.30
US$1,388,651 		3,504 396.30 US$1,388,651
2025-03-05 2025-03-05 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
3,504 -25.7%
396.30
US$1,388,635 		3,504 -25.7% 396.30 US$1,388,635
2024-10-18 2024-10-18 PrS Proposed sale
3.2
Kendrick Charles Morgan JR

Director

Non-Executive Director
7,417
432.28
US$3,206,221 		7,417 432.28 US$3,206,221
2024-10-18 2024-10-18 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
7,417 -46.8%
432.14
US$3,205,182 		7,417 -46.8% 432.14 US$3,205,182
2024-08-06 2024-08-05 PlS Planned sale
3.6
PERU RAMIRO G
Non-Executive Director
753 -7.9%
531.52
US$400,235 		753 -7.9% 531.52 US$400,235
2024-08-05 2024-08-05 PrS Proposed sale
3.6
RAMIRO G PERU

Director

Non-Executive Director
753
531.52
US$400,235 		753 531.52 US$400,235
2024-07-23 2024-07-22 PlS Planned sale
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
2,250 -1.7%
504.27
US$1,134,608 		2,250 -1.7% 504.27 US$1,134,608
2024-07-23 2024-07-22 PlS Planned sale
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
1,000 -0.8%
503.67
US$503,670 		1,000 -0.8% 503.67 US$503,670
2024-07-23 2024-07-22 PlS Planned sale
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
2,250 -1.7%
502.23
US$1,130,018 		2,250 -1.7% 502.23 US$1,130,018
2024-07-23 2024-07-22 PlS Planned sale
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
6,621 -4.8%
501.40
US$3,319,769 		6,621 -4.8% 501.40 US$3,319,769
2024-07-23 2024-07-22 PlS Planned sale
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
20,779 -13.0%
500.36
US$10,396,980 		20,779 -13.0% 500.36 US$10,396,980
2024-07-23 2024-07-22 PlS Planned sale
3.8
BOUDREAUX GAIL

President and CEO

Executive Director
1,100 -0.7%
498.50
US$548,350 		1,100 -0.7% 498.50 US$548,350
2024-07-22 2024-07-22 PrS Proposed sale
3.8
GAIL A KOZIARA BOUDREAUX

Officer; Director

Executive Director
34,000
500.98
US$17,033,398 		34,000 500.98 US$17,033,398
2024-07-22 2024-07-19 S Sale
3.6
Dixon Robert L JR
Non-Executive Director
305 -3.0%
506.76
US$154,562 		305 -3.0% 506.76 US$154,562
2024-07-19 2024-07-19 PrS Proposed sale
3.6
ROBERT DIXON

Director

Non-Executive Director
305
506.76
US$154,562 		305 506.76 US$154,562
2024-04-25 2024-04-24 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
3,434 -11.2%
532.68
US$1,829,223 		3,434 -11.2% 532.68 US$1,829,223
2024-04-25 2024-04-24 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
2,765 -8.3%
532.14
US$1,471,367 		2,765 -8.3% 532.14 US$1,471,367
2024-04-25 2024-04-23 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
100 -0.3%
534.74
US$53,474 		100 -0.3% 534.74 US$53,474
2024-04-25 2024-04-23 S Sale
2.1
Norwood Felicia F

EVP & President,Gov Health Ben

Officer
14,011 -30.7%
533.73
US$7,478,091 		14,011 -30.7% 533.73 US$7,478,091
2024-04-23 2024-04-23 PrS Proposed sale
2.1
Norwood Felicia F

Officer

Officer
20,310
533.60
US$10,837,416 		20,310 533.60 US$10,837,416
2024-03-12 2024-03-08 S Sale
3.2
Kendrick Charles Morgan JR

EVP & President, Commercial

Officer
2,432 -13.3%
500.46
US$1,217,119 		2,432 -13.3% 500.46 US$1,217,119
2024-03-08 2024-03-08 PrS Proposed sale
3.2
Kendrick Charles Morgan JR

Officer

Officer
2,432
500.46
US$1,217,119 		2,432 500.46 US$1,217,119
2024-03-08 2024-03-06 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
916 -34.2%
504.58
US$462,195 		916 -34.2% 504.58 US$462,195
2024-03-06 2024-03-06 PrS Proposed sale
2.7
Penczek Ronald W

Officer

Officer
916
504.58
US$462,197 		916 504.58 US$462,197
2024-03-05 2024-03-04 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres Carelon & CarelonRx

Officer
15,000 -44.3%
500.18
US$7,502,700 		15,000 -44.3% 500.18 US$7,502,700
2024-03-05 2024-03-04 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres Carelon & CarelonRx

Officer
1,889 -5.3%
500.18
US$944,840 		1,889 -5.3% 500.18 US$944,840
2024-03-05 2024-03-04 PlS Planned sale
1.4
Haytaian Peter D

EVP & Pres Carelon & CarelonRx

Officer
4,206 -10.5%
500.18
US$2,103,757 		4,206 -10.5% 500.18 US$2,103,757
2024-03-04 2024-03-04 PrS Proposed sale
1.4
PETER D HAYTAIAN

Officer

Officer
21,095
500.18
US$10,551,297 		21,095 500.18 US$10,551,297
2024-02-09 2024-02-07 PlS Planned sale
3.6
PERU RAMIRO G
Non-Executive Director
753 -7.6%
500.00
US$376,500 		753 -7.6% 500.00 US$376,500
2024-02-07 2024-02-07 PrS Proposed sale
3.6
RAMIRO G PERU

Director

Non-Executive Director
753
500.00
US$376,500 		753 500.00 US$376,500
2023-12-15 2023-12-14 S Sale
1.6
Todt Blair Williams

EVP, CLO & CAO

Officer
5,492 -30.5%
484.02
US$2,658,238 		5,492 -30.5% 484.02 US$2,658,238
2023-12-14 2023-12-14 PrS Proposed sale
1.6
Todt Blair Williams

Officer

Officer
5,492
484.02
US$2,658,238 		5,492 484.02 US$2,658,238
2023-12-01 2023-11-30 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
1,055 -37.1%
475.17
US$501,304 		1,055 -37.1% 475.17 US$501,304
2023-11-30 2023-11-30 PrS Proposed sale
2.7
Penczek Ronald W

Officer

Officer
1,055
475.17
US$501,300 		1,055 475.17 US$501,300
2023-10-26 2023-10-24 S Sale
2.7
Penczek Ronald W

CAO & Controller

Officer
64 -2.2%
454.35
US$29,078 		64 -2.2% 454.35 US$29,078
2023-07-21 2023-07-21 PrS Proposed sale
3.6
ROBERT DIXON JR

Director

Non-Executive Director
310
476.71
US$147,781 		310 476.71 US$147,781

See older Elevance Health Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Elevance Health Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Elevance Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America
Insider trades in S&P 500